ArticleJournal of cardiovascular pharmacology2018

Comparative Evaluation of Gemcabene and Peroxisome Proliferator-Activated Receptor Ligands in Transcriptional Assays of Peroxisome Proliferator-Activated Receptors: Implication for the Treatment of Hyperlipidemia and Cardiovascular Disease.

Charles L Bisgaier et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.